In this CME article, review the current treatment modalities for noninvasive brain stimulation in the treatment of substance use disorders, and to explore the potential for further expansion of indications.
Following implementation of low-dose rituximab as standard of care for muscle-specific kinase–positive myasthenia gravis (MuSK-MG), a hospital evaluated the treatment’s efficacy over a 2-year period.
Children assigned to chew sugar-free gum purportedly score 3% higher on standardized tests of math skills (as widely reported in the press). But is this just one of the 5% of all possible untrue hypotheses statistically guaranteed to have some significant result in its favor (in fact, it's worse than that)?
Boca Raton (PRWEB) February 28, 2023 -- The first of its kind BRAIN & PAIN Summit is a 4-day conference featuring courses about the central nervous system and
In this study, we applied bibliometric methods to analyze the current research situation of acupuncture intervention in CP, to gain insight into this field.
COQ 10: Treats Heart Failure? modernghana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernghana.com Daily Mail and Mail on Sunday newspapers.
Some studies show that low serum vitamin D levels are associated with white matter hyperintensity (WMH）, while other studies report no association. This meta-analysis aimed to investigate the presence of an association between serum 25-hydroxy vitamin D [25(OH)D] levels andWMH. PubMed, Embase, the Cochrane Library, CNKI, WANFANG, and VIP were searched for available papers published up to December 2020. The outcomes were the odds ratios (ORs) with 95% confidence intervals (CIs) for the association between different vitamin D statuses andWMH. All meta-analyses were performed using a random-effects model. Five studies (4393 patients) were included. Compared with sufficient 25(OH)D levels, 25(OH)D deficiency was not associated with WMH(OR=1.67, 95%CI: 0.92-3.04; I2=70.2%, Pheterogeneity=0.009), nor was 25(OH)D insufficiency (OR=1.21, 95%CI: 0.89-1.65; I2=48.1%, Pheterogeneity=0.103) (Figure 3). A decrease of 25 nmol/L in 25(OH)D levels was associated with WMH(OR=1.83, 95%CI: 1.34-2.49; I2=0%, Pheterogeneity=0.512). The sensitivity analyses showed that the results were robust. 25(OH)D deficiency and insufficiency are not associated withWMH. A decrease of 25 nmol/L in 25(OH)D levels was associated withWMH, but this result will have to be confirmed. Prospective trials, both cross-sectional and longitudinal, are necessary to examine the association between 25(OH)D levels andWMH.